Extrapyramidal symptoms with addition of lithium to neuroleptics.
Murphy
D J
DJ
Gannon
M A
MA
Hartman
M L
ML
D014150:Antipsychotic Agents / Q000627:therapeutic use*; D001480:Basal Ganglia Diseases / Q000139:chemically induced*; D004359:Drug Therapy, Combination; D006801:Humans; D008094:Lithium / Q000009:adverse effects* / Q000627:therapeutic use
D014150:Antipsychotic Agents; D008094:Lithium